Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Bristol-Myers Squibb Company - SIC # 2830 -
Ticker
Exchange
SIC #
Website
Latest Ticker
BMY
New York
2830
www.bms.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Bristol-Myers Squibb Company
BMY Q3 deep dive: pipeline advances offset margin pressure as guidance shifts
- Nov 2nd, 2026 2:57 pm
AbbVie vs. Bristol Myers Squibb: Which Healthcare Stock Is a Better Buy for 2027?
- Nov 2nd, 2026 9:20 am
5 must-read analyst questions from Bristol-Myers Squibb’s Q3 earnings call
- Nov 2nd, 2026 7:29 am
TEM Stock Jumps On Upbeat Revenue, Raised Outlook — Cathie Wood’s ARK Buys Over 154K Shares Ahead Of Earnings
- Nov 2nd, 2026 6:14 am
Tempus AI’s Cancer Screen Business Drives Revenue Up 23%, While a Major Purchase Draws Closer
- Nov 2nd, 2026 6:11 am
BMY Up 3% Post Q3 Earnings: Should You Buy, Sell or Hold the Stock?
- Nov 2nd, 2026 5:45 am
Bristol Myers Squibb Stock: Is Wall Street Bullish or Bearish?
- Nov 2nd, 2026 4:34 am
What Invesco S&P Ultra Dividend Revenue ETF (RDIV) Bought: Chevron Leads on Oct. 29
- Nov 2nd, 2026 4:05 am
43 ETFs Add to Bristol-Myers Squibb (BMY) on Oct. 29
- Nov 2nd, 2026 4:01 am
What Bristol Myers Squibb Stock's Earnings Beat Means For Shareholders
- Oct 31st, 2026 5:13 pm
Bristol Myers Squibb (BMY) Reports Positive Phase 2 Pumitamig Lung Cancer Data
- Oct 31st, 2026 6:12 am
MarketBeat Week in Review – 10/26 - 10/30
- Oct 31st, 2026 5:00 am
AstraZeneca Has an $80 Billion Dream and a Plan to Fix Its Stalling Stock
- Oct 30th, 2026 8:21 am
BMY Q3 Earnings Call Highlights Raised Outlook and Pipeline Progress
- Oct 30th, 2026 7:00 am
Pfizer Yields Nearly 6%, but Its Dividend Exceeds Free Cash Flow. Is It Safe?
- Oct 30th, 2026 6:37 am
Is 50% Crash Risk For Iovance Stock Real?
- Oct 30th, 2026 6:32 am
Eli Lilly’s tirzepatide outperforms big pharma companies in Q3
- Oct 30th, 2026 6:16 am
Company News for Oct 30, 2026
- Oct 30th, 2026 2:39 am
Bristol Myers Squibb Q3 Earnings Call Highlights
- Oct 29th, 2026 9:14 pm
What Exelixis (EXEL) Said on Its Q3 Earnings Call
- Oct 29th, 2026 6:14 pm
Scroll